Project Summary
The first step to initiate development of a new organism is to convert the terminally-differentiated mature
oocyte to a totipotent cell capable of undertaking development upon fertilization. This change in cell state,
called egg activation, includes the resumption of meiosis from its arrest in the mature oocyte and the
translation of some stored maternal mRNAs and the degradation of others. Although these events are
critical for fertility, what induces egg activation is not understood, except that a rise in oocyte calcium level is
required. Since the transition initiates with no new transcription or translation, we hypothesized that post-
translational switches mediate the transition from oocyte to activated egg by turning on or off the activity of
proteins present in the egg. Consistent with this hypothesis, we found that the phospho-states of many
proteins change during egg activation in Drosophila; this has since been seen in three other taxa. We
hypothesize that calcium activates enzymes that regulate the phospho-state of critical proteins in the
oocyte, allowing these proteins to then mediate critical egg activation events. We will test this hypothesis
using Drosophila, whose large oocytes, excellent genetics, ‘omics tools, and high conservation of
biomedically-relevant genes provide an optimal system for answering these questions.
The first aim stems from our findings that a conserved mechanically-gated cation channel (TRPM) initiates a
calcium rise in the oocyte and that the calcium-regulated phosphatase calcineurin, which is necessary for
egg activation, is required for a significant fraction of the phosphoproteome changes. Molecules other than
TRPM can then cause a slower, important, rise in calcium. We will determine their nature and contributions
(Aim 1a). Because phosphorylation of some proteins increases upon egg activation, we will determine
whether the calcium-regulated kinase CaMKII is also needed for egg activation in Drosophila, as it is in
mouse (Aim 1b). In Aim 2, we will dissect the events downstream of those studied in Aim 1. By manipulating
kinase activity using optogenetics, we will determine the effect on egg activation of altering the proteome’s
phospho-state (Aim 2a). We will then focus on selected phospho-regulated proteins, particularly those
involved in cell cycle control and translation initiation, testing whether the phospho-modifications that occur
during egg activation alter their activity in ways that facilitate egg activation processes (Aim 2b).
Given the conservation of egg activation, the mechanisms we define should reveal the basis of some pre-
implantation-stage infertilities in humans (including identifying cases that would not be treatable with IVF)
and for assessing the efficacy of IVF conditions. Our results will also help to understand the mechanisms by
which calcium regulates myriad cell processes and their transitions.
Public Health Relevance Statement
Narra$ve
While essen)al for development, the transi)on from mature oocyte to embryo is poorly understood at
the molecular level, largely due to technical limita)ons with studying this process in mammals. We will
use Drosophila to dissect the nature and consequences of the evolu)onarily conserved calcium increase
and protein-modifica)on changes that mediate this transi)on, exploi)ng the fruit fly’s large eggs and
excellent gene)c tools. In addi)on to contribu)ng to our basic understanding of how calcium changes
cell fates, the results of this research will shed light on infer)li)es in people, including assessing who will
or will not benefit from IVF.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
09-December-2024
Project End Date
30-November-2029
Budget Start Date
09-December-2024
Budget End Date
30-November-2025
Project Funding Information for 2025
Total Funding
$335,955
Direct Costs
$215,000
Indirect Costs
$120,955
Year
Funding IC
FY Total Cost by IC
2025
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$335,955
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01HD114777-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HD114777-01A1
Patents
No Patents information available for 1R01HD114777-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HD114777-01A1
Clinical Studies
No Clinical Studies information available for 1R01HD114777-01A1
News and More
Related News Releases
No news release information available for 1R01HD114777-01A1
History
No Historical information available for 1R01HD114777-01A1
Similar Projects
No Similar Projects information available for 1R01HD114777-01A1